Total Payments
$3,725
2024 Payments
$836.40
Companies
16
Transactions
57
Medicare Patients
352
Medicare Billing
$20,307
Payment Breakdown by Category
Food & Beverage$3,725 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,725 | 57 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan, Inc. | $1,029 | 16 | $0 (2022) |
| Bausch & Lomb Americas Inc. | $489.29 | 9 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $456.91 | 6 | $0 (2023) |
| Bausch & Lomb, a division of Bausch Health US, LLC | $314.53 | 4 | $0 (2020) |
| Horizon Therapeutics plc | $288.67 | 4 | $0 (2023) |
| Regeneron Healthcare Solutions, Inc. | $176.32 | 3 | $0 (2024) |
| Amgen Inc. | $173.25 | 3 | $0 (2024) |
| Shire North American Group Inc | $133.48 | 1 | $0 (2017) |
| Genentech USA, Inc. | $126.59 | 1 | $0 (2018) |
| Aerie Pharmaceuticals, Inc. | $125.00 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $836.40 | 16 | Bausch & Lomb Americas Inc. ($365.20) |
| 2023 | $366.75 | 9 | Horizon Therapeutics plc ($178.54) |
| 2022 | $531.07 | 8 | Allergan, Inc. ($170.14) |
| 2021 | $566.65 | 10 | Allergan, Inc. ($566.65) |
| 2020 | $165.47 | 3 | Allergan, Inc. ($125.00) |
| 2019 | $696.21 | 6 | Bausch & Lomb, a division of Bausch Health US, LLC ($274.06) |
| 2018 | $392.12 | 3 | Novartis Pharmaceuticals Corporation ($140.53) |
| 2017 | $169.95 | 2 | Shire North American Group Inc ($133.48) |
All Payment Transactions
57 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/01/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug) | Food and Beverage | In-kind items and services | $35.59 | General |
| Category: Ophthalmology | ||||||
| 10/23/2024 | Dompe US, Inc. | OXERVATE (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: SOLUTION/ DROPS | ||||||
| 10/21/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $30.65 | General |
| Category: EYE CARE | ||||||
| 10/15/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Inflammation/Rare Disease | ||||||
| 09/16/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $24.97 | General |
| Category: ONCOLOGY | ||||||
| 07/31/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Food and Beverage | In-kind items and services | $60.26 | General |
| Category: Ophthalmology | ||||||
| 07/23/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Ophthalmology | ||||||
| 07/11/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $22.89 | General |
| Category: Inflammation/Rare Disease | ||||||
| 06/26/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug) | Food and Beverage | In-kind items and services | $18.03 | General |
| Category: Ophthalmology | ||||||
| 06/13/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $28.75 | General |
| Category: ONCOLOGY | ||||||
| 05/23/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $25.36 | General |
| Category: Inflammation/Rare Disease | ||||||
| 04/27/2024 | CooperVision Inc. | Ortho-K Contact Lens (Device) | Food and Beverage | In-kind items and services | $53.00 | General |
| Category: Devices | ||||||
| 04/26/2024 | Bausch & Lomb Americas Inc. | XIIDRA (Drug), MIEBO | Food and Beverage | In-kind items and services | $9.95 | General |
| Category: Ophthalmology | ||||||
| 04/12/2024 | Bausch & Lomb Americas Inc. | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $14.79 | General |
| Category: Ophthalmology | ||||||
| 04/10/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Ophthalmology | ||||||
| 01/29/2024 | Bausch & Lomb Americas Inc. | XIIDRA (Drug), MIEBO | Food and Beverage | In-kind items and services | $12.18 | General |
| Category: Ophthalmology | ||||||
| 12/08/2023 | Sun Pharmaceutical Industries Inc. | Cequa (Drug) | Food and Beverage | In-kind items and services | $13.90 | General |
| Category: Ophthalmology | ||||||
| 10/31/2023 | Bausch & Lomb Americas Inc. | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $101.87 | General |
| Category: Ophthalmology | ||||||
| 09/22/2023 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $24.32 | General |
| Category: TEPEZZA | ||||||
| 08/01/2023 | Novartis Pharmaceuticals Corporation | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $28.24 | General |
| Category: Ophthalmology | ||||||
| 06/14/2023 | Sun Pharmaceutical Industries Inc. | Cequa (Drug) | Food and Beverage | In-kind items and services | $14.49 | General |
| Category: Ophthalmology | ||||||
| 06/07/2023 | Novartis Pharmaceuticals Corporation | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $14.24 | General |
| Category: Ophthalmology | ||||||
| 05/08/2023 | Novartis Pharmaceuticals Corporation | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $15.47 | General |
| Category: Ophthalmology | ||||||
| 05/04/2023 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $29.22 | General |
| Category: TEPEZZA | ||||||
| 02/28/2023 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: TEPEZZA | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 66 | 75 | $26,297 | $2,863 |
| 2022 | 4 | 141 | 158 | $42,001 | $11,184 |
| 2021 | 3 | 72 | 77 | $29,810 | $3,166 |
| 2020 | 4 | 73 | 81 | $32,116 | $3,094 |
Total Patients
352
Total Services
391
Medicare Billing
$20,307
Procedure Codes
15
All Medicare Procedures & Services
15 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 92012 | Established patient problem focused exam of visual system | Facility | 2023 | 42 | 50 | $19,672 | $1,901 | 9.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 13 | 14 | $5,833 | $844.34 | 14.5% |
| 92202 | Extended exam of the back part of the eye with optic nerve drawing | Facility | 2023 | 11 | 11 | $792.00 | $117.54 | 14.8% |
| 92012 | Established patient problem focused exam of visual system | Office | 2022 | 51 | 55 | $6,730 | $4,638 | 68.9% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 22 | 23 | $4,240 | $2,736 | 64.5% |
| 92012 | Established patient problem focused exam of visual system | Facility | 2022 | 40 | 49 | $21,021 | $1,903 | 9.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 17 | 20 | $8,780 | $1,011 | 11.5% |
| 92002 | New patient problem focused exam of visual system | Office | 2022 | 11 | 11 | $1,230 | $895.46 | 72.8% |
| 92012 | Eye and medical examination for diagnosis and treatment, established patient | Facility | 2021 | 38 | 40 | $17,240 | $1,712 | 9.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 22 | 25 | $10,998 | $1,286 | 11.7% |
| 92020 | Examination of cornea and iris using lens device and slit lamp | Facility | 2021 | 12 | 12 | $1,572 | $168.57 | 10.7% |
| 92012 | Eye and medical examination for diagnosis and treatment, established patient | Facility | 2020 | 26 | 29 | $12,151 | $1,110 | 9.1% |
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | Facility | 2020 | 17 | 18 | $10,728 | $917.78 | 8.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 18 | 21 | $7,560 | $874.58 | 11.6% |
| 92020 | Examination of cornea and iris using lens device and slit lamp | Facility | 2020 | 12 | 13 | $1,677 | $191.44 | 11.4% |
About Dr. Rebecca Moran, O.D
Dr. Rebecca Moran, O.D is a Optometrist healthcare provider based in Bronx, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/01/2016. The National Provider Identifier (NPI) number assigned to this provider is 1811349863.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Rebecca Moran, O.D has received a total of $3,725 in payments from pharmaceutical and medical device companies, with $836.40 received in 2024. These payments were reported across 57 transactions from 16 companies. The most common payment nature is "Food and Beverage" ($3,725).
As a Medicare-enrolled provider, Moran has provided services to 352 Medicare beneficiaries, totaling 391 services with total Medicare billing of $20,307. Data is available for 4 years (2020–2023), covering 15 distinct procedure/service records.
Ad
Practice Information
- Specialty Optometrist
- Location Bronx, NY
- Active Since 07/01/2016
- Last Updated 07/01/2016
- Taxonomy Code 152W00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1811349863
Products in Payments
- XIIDRA (Drug) $456.29
- LUMIGAN (Drug) $434.14
- MIEBO (Drug) $328.28
- TEPEZZA (Drug) $288.67
- TRAVATAN Z (Drug) $272.89
- RESTASIS (Drug) $247.94
- RESTASIS MULTIDOSE (Drug) $207.41
- VUITY (Drug) $193.11
- TEPEZZA (Biological) $173.25
- ALDEN SCLERAL ZENLENS (Device) $148.61
- Lucentis (Biological) $126.59
- Rhopressa (Drug) $125.00
- OXERVATE (Drug) $124.99
- EYLEA (Biological) $122.60
- Acuvue (Device) $79.54
- Cequa (Drug) $63.98
- LIBTAYO (Biological) $53.72
- Ortho-K Contact Lens (Device) $53.00
- VYZULTA (Drug) $47.17
- Prokera (Device) $36.47
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Optometrist Doctors in Bronx
Dr. Albert Contento, O.d.,F.a.a.o, O.D.,F.A.A.O
Optometrist — Payments: $13,645
Optometrist $13,645
Dr. David Garcia, Od, OD
Optometrist — Payments: $12,538
Optometrist $12,538
Elizabeth Yusupov, O.d, O.D
Optometrist — Payments: $9,584
Optometrist $9,584
Dr. Peter Bae, Od, OD
Optometrist — Payments: $8,607
Optometrist $8,607
Katari Campbell, Do, DO
Optometrist — Payments: $7,408
Optometrist $7,408
Dr. Eleonora Orloff
Optometrist — Payments: $6,681
Optometrist $6,681